The Alzheimer's disease assessment scale: Evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease

Alzheimer Disease and Associated Disorders

Volumn 15, Issue 4, 2001, Pages 174-183

  Doraiswamy, P Murali ^a   Kaiser, Lee ^b   Bieber, Florian ^b   Garman, Robert L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

Clinical trials; Dementia; Memory; Neuropsychological tests

Indexed keywords

ACCURACY; ADULT; AGE; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE; ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; EDUCATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MULTICENTER STUDY; OUTPATIENT CARE; PREDICTION; PRIORITY JOURNAL; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; WORD RECOGNITION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COGNITION DISORDERS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; MULTICENTER STUDIES; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS; PLACEBO EFFECT; PSYCHOMETRICS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS;

EID: 0035209309     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-200110000-00003     Document Type: Article

References (24)

1. Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: A clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's disease
2. Population-based norms for the mini-mental state examination by age and educational level
3. A double-blind multicenter study of tacrine for Alzheimer's disease
4. Cognitive performance on the Alzheimer's Disease Assessment Scale: Effect of education
5. NSAID use and cognition in Alzheimer's disease
6. Gender, concurrent estrogen use and cognition in Alzheimer's disease
7. The Alzheimer's Disease Assessment Scale: Patterns and predictors of baseline cognitive performance
8. Memory, language and praxis: Norms for outpatient Alzheimer's disease populations
9. Variability of the MMSE in dementia
10. Age at onset and rate of progression of Alzheimer's disease
11. Defining meaningful change in Alzheimer' disease trials: The donepezil experience
12. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
13. Education and socio-economic determinants of dementia and Alzheimer's disease
14. Estrogen deficiency and risk of Alzheimer's disease in women
15. The global deterioration scale for assessment of primary degenerative dementia
16. Nonsteroidal anti-inflammatory drugs in Alzheimer's disease
17. Gender differences in language of AD patients: A longitudinal study
18. A new rating scale for Alzheimer's disease
19. Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer's disease
20. Deterioration on the Blessed test in Alzheimer's disease: Longitudinal data and their implications for clinical trials and identification of subtypes
21. A longitudinal study of Alzheimer's disease: Measurement, rate, and predictors of cognitive deterioration
22. Alzheimer Disease Assessment Scale: Useful for both early detection and staging of dementia of the Alzheimer type
23. Alzheimer's Disease Assessment Scale: A subtest analysis